Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03243630 · ClinicalTrials.gov registry record · Early Phase 1

Effects of Flavors on Nicotine Reinforcement in Smokers

A Early Phase 1 study, sponsored by Yale University.

Completed
Registry status
Early Phase 1
Development phase
26
Enrollment target

NCT03243630 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03243630, a Early Phase 1 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Early Phase 1
Development phase
26 participants
Enrollment target

Study Summary

To examine the acute reinforcing effects of menthol, a fruit flavor (green apple) or a fruit flavor plus menthol, alone or in combination with nicotine in smokers. Flavors will be administered by inhalation via electronic cigarettes (e-cigarettes) and nicotine will be administered intravenously. The reinforcing drug effects will be measured with the drug effects questionnaire (DEQ).

Interventions

  • DRUG IV nicotine
  • DRUG Menthol flavor
  • DRUG green apple
  • DRUG green apple and menthol

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2018-04-23
Est. Completion 2019-01-31
Phase Early Phase 1

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT03243630

The ClinicalTrials.gov registry entry for NCT03243630 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which IV nicotine is the first listed.

NCT03243630 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03243630 about?

NCT03243630 is a clinical study titled "Effects of Flavors on Nicotine Reinforcement in Smokers". To examine the acute reinforcing effects of menthol, a fruit flavor (green apple) or a fruit flavor plus menthol, alone or in combination with nicotine in smokers. Flavors will be administered by inhalation via electronic cigarettes (e-cigarettes) and nicotine will be administered intravenously. The...

What is the current status of trial NCT03243630?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 26 participants. The study started on 2018-04-23. Estimated completion is 2019-01-31.

What interventions are being tested in trial NCT03243630?

The interventions under investigation include: IV nicotine (DRUG), Menthol flavor (DRUG), green apple (DRUG), green apple and menthol (DRUG).

Who is sponsoring clinical trial NCT03243630?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.